Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study
Ramón García‐Sánz, Roger G. Owen, Wojciech Jurczak, Meletios A Dimopoulos, Helen O. McCarthy, Gavin Cull, Stephen Opat, Jorge J. Castillo, Marie José Kersten, Björn E. Wahlin, Sebastian Grosicki, Radha Prathikanti, Tian Tian, Heather Allewelt, Aileen Cohen, Constantine S. Tam (2025). Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study. , 9(24), DOI: https://doi.org/10.1182/bloodadvances.2024015596.
Article43 days agoDexamethasone, Rituximab and Cyclophosphamide with Bortezomib is a rapidly acting and highly efficient first-line treatment in Waldenström's Macroglobulinemia: Final analysis of ECWM-1 trial of the European Consortium for Waldenström's Macroglobulinemia (ECWM)
Pierre Morel, Christian Buske, Alexander Grunenberg, Efstathios Kastritis, Lydia Montes, Cécile Tomowiak, Roman Hájek, Andreas Viardot, Olivier Tournilhac, Thérèse Aurran, Florian Bouclet, Hacène Zerazhi, Bénédicte Hivert, Damien Roos‐Weil, Sophie de Guibert, Lena Brandefors, Ramón García‐Sánz, Maria Fátima das Graças Fernandes da Silva, Eva Kimby, Birgit Schmelzle, Dajana Kaszynski, Mélanie Verlay, Caroline Skrzypczak, Jens Dreyhaupt, Rainer Muche, Meletios A Dimopoulos (2025). Dexamethasone, Rituximab and Cyclophosphamide with Bortezomib is a rapidly acting and highly efficient first-line treatment in Waldenström's Macroglobulinemia: Final analysis of ECWM-1 trial of the European Consortium for Waldenström's Macroglobulinemia (ECWM). , 146(Supplement 1), DOI: https://doi.org/10.1182/blood-2025-223.
Article43 days agoHealth-related quality of life in patients with Waldenström macroglobulinemia: results from the ASPEN trial
Alessandra Tedeschi, Constantine S. Tam, Roger G. Owen, Christian Buske, Véronique Leblond, Meletios A Dimopoulos, Ramón García‐Sánz, Jorge J. Castillo, Judith Trotman, Steven P. Treon, Keri Yang, Boxiong Tang, Heather Allewelt, Sheel Patel, Wai‐Yee Chan, Aileen Cleary Cohen, Shengnan Chen, Gisoo Barnes (2024). Health-related quality of life in patients with Waldenström macroglobulinemia: results from the ASPEN trial. , 20(25), DOI: https://doi.org/10.1080/14796694.2024.2355079.
Article43 days agoBiomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia
Constantine S. Tam, Stephen Opat, Shirley D’Sa, Wojciech Jurczak, Hui‐Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton, Björn E. Wahlin, Ramón García‐Sánz, Helen O. McCarthy, Stephen P. Mulligan, Alessandra Tedeschi, Jorge J. Castillo, Jarosław Czyż, Carlos Fernández de Larrea, David Belada, Edward N. Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trněný, Monique C. Minnema, Christian Buske, Véronique Leblond, Steven P. Treon, Judith Trotman, Binghao Wu, Yiling Yu, Zhirong Shen, Wai‐Yee Chan, Jingjing Schneider, Heather Allewelt, Aileen Cohen, Meletios A Dimopoulos (2024). Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia. , 8(7), DOI: https://doi.org/10.1182/bloodadvances.2023010906.
Article43 days agoReport of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria
Steven P. Treon, Alessandra Tedeschi, Jesús F. San Miguel, Ramón García‐Sánz, Kenneth C. Anderson, Eva Kimby, Monique C. Minnema, Giulia Benevolo, Lugui Qiu, Shuhui Yi, Evangelos Terpos, Constantine S. Tam, Jorge J. Castillo, Pierre Morel, Meletios A Dimopoulos, Roger G. Owen (2023). Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria. , 60(2), DOI: https://doi.org/10.1053/j.seminhematol.2023.03.009.
Article43 days ago